Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients. [electronic resource]
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Nov 2014
- A487-8 p. digital